Profil
Angus George Dalgleish was the founder of Onyvax Ltd. which was founded in 1997, where he held the title of Research Director from 2009 to 2012.
He is currently a Member-Cancer Board at The European Commission.
He was a Chief Medical Officer at Biostax Corp.
in 2013.
Dr. Dalgleish received his undergraduate and doctorate degrees from University College London.
Postes actifs de Angus George Dalgleish
| Sociétés | Poste | Début |
|---|---|---|
The European Commission
The European Commission General GovernmentGovernment A government commission | Corporate Officer/Principal | - |
Anciens postes connus de Angus George Dalgleish
| Sociétés | Poste | Fin |
|---|---|---|
| BIOSTAXPAR | Directeur Technique/Scientifique/R&D | - |
Onyvax Ltd.
Onyvax Ltd. Miscellaneous Commercial ServicesCommercial Services Develops cancer remedy therapies | Fondateur | - |
Formation de Angus George Dalgleish
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Onyvax Ltd.
Onyvax Ltd. Miscellaneous Commercial ServicesCommercial Services Develops cancer remedy therapies | Commercial Services |
University College London
University College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The European Commission
The European Commission General GovernmentGovernment A government commission | Government |
Biostax Corp.
Biostax Corp. Pharmaceuticals: MajorHealth Technology Manufactures and develops pharmaceutical & biotechnology products | Health Technology |
















